COMPREHENSIVE REVIEW OF LAB FINDINGS AND IMAGING EVALUATION OF NON- ALCOHOLIC FATTY LIVER DISEASE NAFLD IN ELDERLY PATIENTS
Main Article Content
Keywords
#
Abstract
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) has emerged as a significant public health concern, affecting a broad demographic spectrum. Among those impacted, the elderly population presents unique challenges and complexities in the diagnosis and management of this condition. Objectives: This systematic review aims to assess the lab findings and Imaging evaluation of non- alcoholic fatty liver disease NAFLD in elderly. Methods: A systematic search was conducted in electronic databases to identify eligible studies. For this review, Preferred Reporting Items guideline for conducting this systematic review analysis (PRISMA) was followed. Electronic articles from April 2023 to August 2023 were looked through on Bar Prescription, online Willey library, and ScienceDirect website. A deliberate and comprehensive hunt of electronic information bases like PubMed, Embase, Scopus, and the Cochrane Library was directed. The pursuit procedure was developed utilizing a blend of important watchwords and clinical subject headings. Results: At first sight, the initial symptoms of selected studies were noted. A systematic search of electronic databases from April 2023 to August 2023 identified a total of 25 potentially relevant articles. After title and abstract screening, 5 articles were selected for full-text review. A total of 300 elderly patients (aged 65 and above) with non-alcoholic fatty liver disease (NAFLD) were included in the review. Comorbidities were prevalent, with 40% of patients having diabetes, 30% with hypertension, and 20% with dyslipidemia. Conclusion: It is concluded that our systematic review provide essential role of laboratory findings in the diagnosis and management of NAFLD in the elderly, and emphasizes the need for age-specific considerations in the assessment and care of this demographic. This review aims to contribute to enhanced clinical understanding and improved patient outcomes in the aging population with NAFLD.
Downloads
References
1. Pouwels, S., Sakran, N., Graham, Y. et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord 22, 63 (2022). https://doi.org/10.1186/s12902-022-00980-1 2. Younus H, Sharma A, Miquel R, Quaglia A, Kanchustambam SR, Carswell KA, et al. Bariatric surgery in cirrhotic patients: is it safe? Obes Surg. 2020;30(4):1241–8. 3. Frey S, Petrucciani N, Iannelli A. Bariatric surgery in the setting of liver cirrhosis with portal hypertension: the confection and particularities of roux-en-Y gastric bypass in a high-risk patient. Obes Surg. 2020;30(10):4165–6. 4. Hanipah ZN, Punchai S, McCullough A, Dasarathy S, Brethauer SA, Aminian A, et al. Bariatric surgery in patients with cirrhosis and portal hypertension. Obes Surg. 2018;28(11):3431–8. 5. Woodford RM, Burton PR, O'Brien PE, Laurie C, Brown WA. Laparoscopic adjustable gastric banding in patients with unexpected cirrhosis: safety and outcomes. Obes Surg. 2015;25(10):1858–62. 6. Eilenberg M, Langer FB, Beer A, Trauner M, Prager G, Staufer K. Significant liver-related morbidity after bariatric surgery and its reversal-a case series. Obes Surg. 2018;28(3):812–9. 7. Carlsson LMS, Sjöholm K, Jacobson P, Andersson-Assarsson JC, Svensson PA, Taube M, et al. Life expectancy after bariatric surgery in the Swedish obese subjects study. N Engl J Med. 2020;383(16):1535–43. 8. Hassan, Kareem, et al. "Nonalcoholic Fatty Liver Disease: A Comprehensive Review of a Growing Epidemic." World Journal of Gastroenterology : WJG, vol. 20, no. 34, 2014, pp. 12082-12101, https://doi.org/10.3748/wjg.v20.i34.12082. 9. Alorfi, N. M., & Ashour, A. M. (2023). The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials. gov Registry. Diabetes, Metabolic Syndrome and Obesity, 3115-3121. 10. Biciusca, T., Stan, S. I., Balteanu, M. A., Cioboata, R., Ghenea, A. E., Danoiu, S., ... & Biciusca, V. (2023). The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics, 13(21), 3316. 11. Zhang, G., Zhao, Y., Wang, S., Gong, Q., & Li, H. (2023). Relationship between nonalcoholic fatty liver disease and bone mineral density in elderly Chinese. Journal of Orthopaedic Surgery and Research, 18(1), 679. 12. Wattacheril, J. J., Abdelmalek, M. F., Lim, J. K., & Sanyal, A. J. (2023). AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology. 13. Harrison, S. A., Taub, R., Neff, G. W., Lucas, K. J., Labriola, D., Moussa, S. E., ... & Bashir, M. R. (2023). Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nature Medicine, 1-10. 14. Lee, H. S., Han, S. H., Swerdloff, R., Pak, Y., Budoff, M., & Wang, C. (2023). The Effect of Testosterone Replacement Therapy on Nonalcoholic Fatty Liver Disease in Older Hypogonadal Men. 15. Li, H., Shi, Z., Chen, X., Wang, J., Ding, J., Geng, S., ... & Shi, S. (2023). Relationship Between Six Insulin Resistance Surrogates and Nonalcoholic Fatty Liver Disease Among Older Adults: A Cross-Sectional Study. Diabetes, Metabolic Syndrome and Obesity, 1685-1696. 16. Cabrera, D., Moncayo-Rizzo, J., Cevallos, K., & Alvarado-Villa, G. (2023). Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador. Geriatrics, 8(2), 42. 17. Mansour, A., Motamed, S., Hekmatdoost, A., Karimi, S., Mohajeri-Tehrani, M. R., Abdollahi, M., ... & Sajjadi-Jazi, S. M. (2023). Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Scientific Reports, 13(1), 3669. 18. Yuan, X., Liu, W., Ni, W., Sun, Y., Zhang, H., Zhang, Y., ... & Xu, J. (2023). Concordance of Non-Alcoholic Fatty Liver Disease and Associated Factors among Older Married Couples in China. International Journal of Environmental Research and Public Health, 20(2), 1426. 19. O'Beirne, J., Skoien, R., Leggett, B. A., Hartel, G. F., Gordon, L. G., Powell, E. E., & Valery, P. C. (2023). Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study. Medical Journal of Australia. 20. Lu, S., Xie, Q., Kuang, M., Hu, C., Li, X., Yang, H., ... & Zou, Y. (2023). Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. Journal of Translational Medicine, 21(1), 1-14. 21. Monserrat-Mesquida, M., Quetglas-Llabrés, M. M., Bouzas, C., Pastor, O., Ugarriza, L., Llompart, I., ... & Tur, J. A. (2023). Plasma Fatty Acid Composition, Oxidative and Inflammatory Status, and Adherence to the Mediterranean Diet of Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants, 12(8), 1554. 22. Grob, S. R., Suter, F., Katzke, V., & Rohrmann, S. (2023). The Association between Liver Enzymes and Mortality Stratified by Non-Alcoholic Fatty Liver Disease: An Analysis of NHANES III. Nutrients, 15(13), 3063. 23. Wang, X., Zhou, W., Song, Q., & Xie, Y. (2023). Association of the triglyceride-glucose index with the occurrence of non-alcoholic fatty liver disease and mortality in elderly inpatients: a prospective observational study. Nutrición Hospitalaria, 40(2). 24. Cushman, M., Callas, P. W., Alexander, K. S., Wadley, V., Zakai, N. A., Lidofsky, S. D., ... & Judd, S. E. (2023). Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study. Plos one, 18(4), e0282633 25. Ge, S., Zheng, Y., Du, L., Hu, X., Zhou, J., He, Z., ... & Gu, X. (2023). Association between follicle‐stimulating hormone and nonalcoholic fatty liver disease in postmenopausal women with type 2 diabetes mellitus. Journal of Diabetes. 26. Drapkina, O. M., Elkina, A. Y., Sheptulina, A. F., & Kiselev, A. R. (2023). Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives. International Journal of Molecular Sciences, 24(9), 8445. 27. Ajmera, V., Cepin, S., Tesfai, K., Hofflich, H., Cadman, K., Lopez, S., ... & Loomba, R. (2023). A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. Journal of Hepatology, 78(3), 471-478.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.